These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy of Bravecto® Plus spot-on solution for cats (280 mg/ml fluralaner and 14 mg/ml moxidectin) in the prevention of feline Aelurostrongylus abstrusus infection evaluated in a multi-diagnostic approach. Raulf MK, Raue K, Rohdich N, Zschiesche E, Raue J, Merhof K, Volk HA, Schnyder M, Morelli S, Traversa D, Roepke RKA, Strube C. Parasit Vectors; 2024 Apr 24; 17(1):193. PubMed ID: 38658960 [Abstract] [Full Text] [Related]
3. Efficacy of imidacloprid 10%/moxidectin 1% spot-on formulation (Advocate®) in the prevention and treatment of feline aelurostrongylosis. Heuer L, Petry G, Pollmeier M, Schaper R, Deuster K, Schmidt H, Blazejak K, Strube C, Di Cesare A, Traversa D, Schnyder M, McKay-Demeler J, von Samson-Himmelstjerna G, Mangold-Gehring S, Böhm C. Parasit Vectors; 2020 Feb 12; 13(1):65. PubMed ID: 32051008 [Abstract] [Full Text] [Related]
4. Efficacy of a spot-on formulation containing 280 mg/ml fluralaner and 14 mg/ml moxidectin (Bravecto® Plus) in the prevention of cat aelurostrongylosis under field conditions. Di Cesare A, Morelli S, Rohdich N, Kirkova Z, Capári B, Loehlein W, Wolf O, Zschiesche E, Colombo M, Astuti C, Traversa D. Vet Parasitol; 2024 Apr 12; 327():110114. PubMed ID: 38286060 [Abstract] [Full Text] [Related]
5. Shedding of feline lungworm larvae and their infectivity to snail intermediate hosts after anthelmintic treatment. Cavalera MA, Colella V, Napoli E, Arfuso F, Panarese R, Brianti E, Otranto D. Int J Parasitol; 2019 May 12; 49(6):449-453. PubMed ID: 30904621 [Abstract] [Full Text] [Related]
6. A randomized, blinded, controlled, multi-centered field study assessing the treatment of gastrointestinal nematode infections in cats with fluralaner plus moxidectin spot-on solution (Bravecto® Plus). Rohdich N, Zschiesche E, Wolf O, Loehlein W, Kirkova Z, Iliev P, Rapti D, Postoli R, Capári B, Farkas R, Roepke RKA. Parasit Vectors; 2018 Nov 19; 11(1):589. PubMed ID: 30449275 [Abstract] [Full Text] [Related]
9. Clinical efficacy of a parasiticide formulation containing eprinomectin, esafoxolaner and praziquantel (NexGard® Combo) in the treatment of natural feline aelurostrongylosis and troglostrongylosis. Di Cesare A, Veronesi F, Crisi PE, Colombo M, Morelli S, Vignoli M, Rigamonti G, Iorio R, Tielemans E, Beugnet F, Gamblin C, Traversa D. Vet Parasitol; 2024 Oct 19; 331():110271. PubMed ID: 39089177 [Abstract] [Full Text] [Related]
10. Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats. Taenzler J, de Vos C, Roepke RKA, Heckeroth AR. Parasit Vectors; 2018 Nov 19; 11(1):595. PubMed ID: 30449272 [Abstract] [Full Text] [Related]
14. Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto® Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis. Fisara P, Guerino F, Sun F. Parasit Vectors; 2019 May 23; 12(1):259. PubMed ID: 31122282 [Abstract] [Full Text] [Related]
17. Detection of specific antibodies in cats infected with the lung nematode Aelurostrongylus abstrusus. Zottler EM, Strube C, Schnyder M. Vet Parasitol; 2017 Feb 15; 235():75-82. PubMed ID: 28215872 [Abstract] [Full Text] [Related]
18. Clinical, laboratory and pathological findings in cats experimentally infected with Aelurostrongylus abstrusus. Schnyder M, Di Cesare A, Basso W, Guscetti F, Riond B, Glaus T, Crisi P, Deplazes P. Parasitol Res; 2014 Apr 15; 113(4):1425-33. PubMed ID: 24504600 [Abstract] [Full Text] [Related]
19. Efficacy of a spot-on combination containing 10% w/v imidacloprid and 1% w/v moxidectin for the treatment of troglostrongylosis in experimentally infected cats. Traversa D, Raue K, Ringeisen H, Blazejak K, Bisterfeld K, Di Cesare A, Colombo M, Böhm C, Strube C, Pollmeier M. Parasit Vectors; 2022 Feb 22; 15(1):66. PubMed ID: 35193656 [Abstract] [Full Text] [Related]
20. Efficacy and safety of emodepside 2.1%/praziquantel 8.6% spot-on formulation in the treatment of feline aelurostrongylosis. Traversa D, Milillo P, Di Cesare A, Lohr B, Iorio R, Pampurini F, Schaper R, Bartolini R, Heine J. Parasitol Res; 2009 Aug 22; 105 Suppl 1():S83-9. PubMed ID: 19575229 [Abstract] [Full Text] [Related] Page: [Next] [New Search]